Clinical TrialID 6822
Cantharidin Application in Molluscum Patients-1
NCT03377790
Molluscum Contagiosum
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6822
- Evidence Id
- 6822
- Core Evidence Id
- 6822
- Source Clinical Trial Id
- 6812
- Herb2 Clinical Trial Id
- HBCT006812
- Nct Id
- NCT03377790
- Title
- Cantharidin Application in Molluscum Patients-1
- Status
- Completed
- Phase
- Phase 3
- Study Result
- Yes
- Study Condition
- Molluscum Contagiosum
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- COMBINATION_PRODUCT: VP-102 - Cantharidin, Topical Film Forming Solution|COMBINATION_PRODUCT: Placebo -Topical Film Forming Solution without VP-102
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Quadruple
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult, Older_Adult
- Enrollment
- 266
- Outcome Measure
- Percentage of Subjects Exhibiting Complete Clearance of All Treatable Molluscum Lesions (Baseline and New) on the Day 84 Visit (EOS), Percentage of subjects exhibiting complete clearance of all treatable molluscum lesions (baseline and new) on the Day 84 visit (EOS)., Day 1 (Baseline and new) compared to Day 84 (EOS)
- Sponsor Collaborator
- Verrica Pharmaceuticals Inc.|Instat Consulting, Inc.|Paidion Research, Inc.|Database Integrations, Inc.
- Funded By
- INDUSTRY
- Location
- Alabama Clinical Therapeutics, Birmingham, Alabama, 35205, United States|Southeastern Pediatric Associates, Dothan, Alabama, 36305, United States|Applied Research Center of Arkansas, Little Rock, Arkansas, 72212, United States|Study Protocol, Inc.,, Boynton Beach, Florida, 33437, United States|Skin Research Institute, Coral Gables, Florida, 33146, United States|ASCLEPES Research Center, Spring Hill, Florida, 34609, United States|Olympian Clinical Research, Tampa, Florida, 33609, United States|Summit Dermatology, Oakbrook Terrace, Illinois, 60181, United States|Clarkston Skin Research, Clarkston, Michigan, 48346, United States|St Louis Children's Hospital, Saint Louis, Missouri, 63104, United States|Midwest Children's Hospital, Lincoln, Nebraska, 68522, United States|Kings County Hospital, Brooklyn, New York, 11203, United States|University North Carolina Dermatology Center, Chapel Hill, North Carolina, 27516, United States|The Pediatric Associates of Fairfield, Inc, Fairfield, Ohio, 45014, United States|Holston Medical Group, Bristol, Tennessee, 37620, United States|Arlington Research Center, Arlington, Texas, 66011, United States|Center for Skin Research, Houston, Texas, 77056, United States|ACRC Trials Plano Pediatrics, Plano, Texas, 75093, United States
- Other Id
- VP-102-101
- Start Date
- 2018-03-21
- Primary Completion Date
- 2018-11-26
- Completion Date
- 2018-11-26
- First Posted
- 2017-12-19
- Results First Posted
- 2021-12-14
- Last Update Posted
- 2022-01-11
- Study Document
- Study Protocol, https://cdn.clinicaltrials.gov/large-docs/90/NCT03377790/Prot_000.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/90/NCT03377790/SAP_001.pdf
- Study Url
- https://clinicaltrials.gov/study/NCT03377790
- Title Cn
- Title En
- Cantharidin Application in Molluscum Patients-1
- Bilingual Status
- semi_complete